Adjunct systemic corticosteroids reduced short-term mortality by 27% in patients with severe pneumonia, a meta-analysis of randomized trials found. Corticosteroid use in acute respiratory distress ...
May reduce secondary shock in severe pneumonia, but have little to no effect on hospital-acquired infections. HealthDay News — Adjunct corticosteroids probably reduce short-term mortality in adults ...
Aridis Pharmaceuticals, Inc. ARDS announced that its AR-301 clinical program is being considered for availing the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (“LPAD”). This ...
Aridis Pharmaceuticals ARDS announced that the FDA has accepted the company’s proposal of a single confirmatory phase III AR-301-003 study of its proprietary monoclonal antibody candidate, AR-301, for ...
Please provide your email address to receive an email when new articles are posted on . Researchers observed high lysolipid levels in those with acute respiratory distress syndrome (ARDS), which may ...
HONOLULU -- As suspected, patients with acute respiratory distress syndrome (ARDS) had particularly bad outcomes if they had coexisting pulmonary hypertension (PH), an analysis of the National ...
In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and ...
Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results